Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Syntrix Biosystems, Inc.

Clinical trials sponsored by Syntrix Biosystems, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New combo therapy aims to fight hard-to-treat prostate cancer Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet finished but already full! 1

New drug aims to unmask melanoma to the immune system

Disease control Ongoing

This early-stage trial tests a new oral drug, SX-682, combined with the immunotherapy pembrolizumab in people with advanced melanoma. The goal is to see if SX-682 can stop cancer from hiding from the immune system, making the immunotherapy work better. About 77 participants will …

Phase 1 • Sponsor: Syntrix Biosystems, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC